Novem Group’s Insulet PODD Stock Holding History

Novem Group’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,433	Closed	-$1.06M	–	463
2025 Q3	$1.06M	Buy	3,433 +108	+3%	+$33.8K	0.12%	155
2025 Q2	$1.04M	Buy	+3,325	New	+$960K	0.13%	130

Other funds holding PODD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Novem Group's PODD Position: Q4 2025 in Review

Novem Group sold out of Insulet (PODD) in Q4 2025, closing a stake of 3,433 shares — an estimated $1.06M sold.

Novem Group first reported a position in PODD in Q2 2025 and held it in 2 quarters. The position peaked at $1.06M in Q3 2025. 834 funds tracked by Wall St. Rank hold PODD as of Q4 2025.

Novem Group reported no remaining Insulet position as of Q4 2025 after selling out during the quarter.
Novem Group sold 3,433 Insulet shares in Q4 2025, an estimated $1.06M.
Novem Group first reported a position in Insulet in Q2 2025 and held it in 2 quarters.
Novem Group's Insulet position peaked at $1.06M in Q3 2025.
834 funds tracked by Wall St. Rank held Insulet as of Q4 2025.

Based on Novem Group's 13F filing for Q4 2025, filed 27 Jan 2026.